FreshPatents.com Logo
stats FreshPatents Stats
1 views for this patent on FreshPatents.com
2014: 1 views
Updated: July 25 2014
newTOP 200 Companies filing patents this week


    Free Services  

  • MONITOR KEYWORDS
  • Enter keywords & we'll notify you when a new patent matches your request (weekly update).

  • ORGANIZER
  • Save & organize patents so you can view them later.

  • RSS rss
  • Create custom RSS feeds. Track keywords without receiving email.

  • ARCHIVE
  • View the last few months of your Keyword emails.

  • COMPANY DIRECTORY
  • Patents sorted by company.

Follow us on Twitter
twitter icon@FreshPatents

Method of increasing stent retention of bioabsorbable scaffolding with a sheath

last patentdownload pdfdownload imgimage previewnext patent


20120290063 patent thumbnailZoom

Method of increasing stent retention of bioabsorbable scaffolding with a sheath


A medical device includes a polymer stent crimped to a catheter having an expansion balloon. The stent is crimped to the balloon by a process that includes heating the stent to a temperature below the polymer's glass transition temperature to improve stent retention without adversely affecting the mechanical characteristics of the stent when later deployed to support a body lumen. A variable diameter sheath with a central portion that prevents expansion of the stent when the balloon is pressurized and larger diameter ends is disposed over the crimped stent-balloon assembly. The balloon is pressurized and the larger diameter ends of the sheath allow the balloon beyond the ends of the stent to expand. The balloon is then depressurized.
Related Terms: Scaffolding

Browse recent Abbott Cardiovascular Systems Inc. patents - Santa Clara, CA, US
Inventors: Yunbing Wang, Xiao Ma, Rommel C. Lumauig
USPTO Applicaton #: #20120290063 - Class: 623 111 (USPTO) - 11/15/12 - Class 623 
Prosthesis (i.e., Artificial Body Members), Parts Thereof, Or Aids And Accessories Therefor > Arterial Prosthesis (i.e., Blood Vessel) >Stent Combined With Surgical Delivery System (e.g., Surgical Tools, Delivery Sheath, Etc.)

view organizer monitor keywords


The Patent Description & Claims data below is from USPTO Patent Application 20120290063, Method of increasing stent retention of bioabsorbable scaffolding with a sheath.

last patentpdficondownload pdfimage previewnext patent

BACKGROUND OF THE INVENTION

1. Field of the Invention

The present invention relates to medical devices; more particularly, this invention relates to methods of making polymeric stent delivery systems.

2. Background of the Invention

The art recognizes a variety of factors that affect a polymeric stent\'s ability to retain its structural integrity when subjected to external loadings, such as crimping and balloon expansion forces. These interactions are complex and the mechanisms of action not fully understood. According to the art, characteristics differentiating a polymeric, bio-absorbable stent scaffolding of the type expanded to a deployed state by plastic deformation from a similarly functioning metal stent are many and significant. Indeed, several of the accepted analytic or empirical methods/models used to predict the behavior of metallic stents tend to be unreliable, if not inappropriate, as methods/models for reliably and consistently predicting the highly non-linear behavior of a polymeric load-bearing, or scaffolding portion of a balloon-expandable stent. The models are not generally capable of providing an acceptable degree of certainty required for purposes of implanting the stent within a body, or predicting/anticipating the empirical data.

Moreover, it is recognized that the state of the art in medical device-related balloon fabrication, e.g., non-compliant balloons for stent deployment and/or angioplasty, provide only limited information about how a polymeric material might behave when used to support a lumen within a living being via plastic deformation of a network of rings interconnected by struts. In short, methods devised to improve mechanical features of an inflated, thin-walled balloon structure, most analogous to mechanical properties of a pre-loaded membrane when the balloon is inflated and supporting a lumen, simply provides little, if any insight into the behavior of a deployed polymeric stent scaffolding. One difference, for example, is the propensity for fracture or cracks to develop in a stent scaffolding. The art recognizes the mechanical problem as too different to provide helpful insights, therefore, despite a shared similarity in class of material. At best, the balloon fabrication art provides only general guidance for one seeking to improve characteristics of a balloon-expanded, bio-absorbable polymeric stent.

Polymer material considered for use as a polymeric stent scaffolding, e.g. PLLA or PLGA, may be described, through comparison with a metallic material used to form a stent scaffolding, in some of the following ways. A suitable polymer has a low strength to weight ratio, which means more material is needed to provide an equivalent mechanical property to that of a metal. Therefore, struts must be made thicker and wider to have the strength needed to support a lumen, for example. The scaffolding also tends to be brittle or have limited fracture toughness. The anisotropic and rate-dependant inelastic properties (i.e., strength/stiffness of the material varies depending upon the rate at which the material is deformed) inherent in the material only compound this complexity in working with a polymer, particularly, bio-absorbable polymer such as PLLA or PLGA.

Processing steps performed on, design changes made to a metal stent that have not typically raised concerns for, or require careful attention to unanticipated changes in the average mechanical properties of the material, therefore, may not also apply to a polymer stent due to the non-linear and sometimes unpredictable nature of the mechanical properties of the polymer under a similar loading condition. It is sometimes the case that one needs to undertake extensive validation before it even becomes possible to predict more generally whether a particular condition is due to one factor or another—e.g., was a defect the result of one or more steps of a fabrication process, or one or more steps in a process that takes place after stent fabrication, e.g., crimping. As a consequence, a change to a fabrication process, post-fabrication process, diameter of the stent, length of the stent, or even relatively minor changes to a stent pattern design must, generally speaking, be investigated more thoroughly than if a metallic material were used instead of the polymer. It follows, therefore, that when choosing among different polymeric stent designs for improvement thereof, there are far less inferences, theories, or systematic methods of discovery available, as a tool for steering one clear of unproductive paths, and towards more productive paths for improvement, than when making changes in a metal stent.

It is recognized, therefore, that, whereas inferences previously accepted in the art for stent validation or feasibility when an isotropic and ductile metallic material was used, such inferences would be inappropriate for a polymeric stent. A change in a polymeric stent pattern may affect not only the stiffness or lumen coverage of the stent in its deployed state supporting a lumen, but also the propensity for fractures to develop when the stent is crimped or being deployed. This means that, in comparison to a metallic stent, there is generally no assumption that can be made as to whether a changed stent pattern may not produce an adverse outcome, or require a significant change in a processing step (e.g., tube forming, laser cutting, crimping, etc.). Simply put, the highly favorable, inherent properties of a metal (generally invariant stress/strain properties with respect to the rate of deformation or the direction of loading, and the material\'s ductile nature), which simplify the stent fabrication process, allow for inferences to be more easily drawn between a changed stent pattern and/or a processing step and the ability for the stent to be reliably manufactured with the new pattern and without defects when implanted within a living being.

A change in the geometry of the stent such as length, diameter, strut thickness, and pattern of the struts and rings of a polymeric stent scaffolding that is plastically deformed, both when crimped to, and when later deployed by a balloon, unfortunately, is not as easy to predict as a metal stent. Indeed, it is recognized that unexpected problems may arise in polymer stent fabrication steps as a result of a changed pattern that would not have necessitated any changes if the pattern was instead formed from a metal tube. In contrast to changes in a metallic stent pattern, a change in polymer stent pattern may necessitate other modifications in fabrication steps or post-fabrication processing, such as crimping and sterilization.

One problem frequently encountered with a stent for delivery to a site in a body using a balloon is reliably retaining the stent on the balloon as it passes through tortuous anatomy. If the stent is not held on the balloon with sufficient force, it can slip off of the balloon during transit to the target site. For a metallic stent, there are several approaches proposed for increasing the retention of a stent to a balloon during transit to the target site. However, methods proposed thus far for retaining the polymer stent on a balloon are in need of improvement.

In light of the foregoing problems, there is a need for improving the retention of a polymer stent on a balloon while avoiding adverse effects on the mechanical characteristics of the load bearing, polymer scaffolding when the scaffolding is fully deployed to support a lumen.

SUMMARY

OF THE INVENTION

Various embodiments of the present invention include a method of making a stent delivery system, comprising the steps of: providing a polymeric scaffolding crimped tightly over a delivery balloon; providing a tubular sheath comprising a middle portion and two end portions, wherein the middle portion of the sheath have an inside diameter equal to or 1-2% larger than the outer diameter of the crimped scaffolding and the end portions of the sheath have a diameter 3-100% greater than the diameter of the crimped scaffolding; disposing the polymeric scaffolding and balloon within the tubular sheath, wherein the middle portion of the sheath is disposed over the scaffolding and the end portions of the sheath extend beyond the ends of the scaffolding over end portions of the balloon; pressurizing the balloon to cause the end portions of the balloon to inflate beyond the outer diameter of the crimped scaffolding; and depressurizing the balloon.

Further embodiments of the present invention include a method of making a stent delivery system, comprising the steps of: providing a polymeric scaffolding; crimping the scaffolding to a final crimped diameter over a balloon to form a crimped stent-balloon assembly, wherein the crimping includes at least one crimping step in which the scaffolding is crimped to a first diameter greater than the final diameter and holding the scaffolding at the first diameter while the balloon is inflated to a pressure against the scaffolding; providing a tubular sheath comprising a central portion; disposing the polymeric stent and balloon within the tubular sheath, wherein the central portion prevents expansion of the stent when the balloon is pressurized; pressurizing the balloon to cause end portions of the balloon proximal and distal to ends of the stent to expand; and depressurizing the balloon.

Additional embodiments of the present invention include a stent delivery system, comprising: a tubular sheath comprising a middle portion and two end portions; a polymeric scaffolding crimped tightly over a delivery balloon, wherein the polymeric scaffolding and balloon are disposed within the tubular sheath; wherein the middle portion of the sheath has an inside diameter equal to or 1-2% larger than the outer diameter of the crimped scaffolding and the end portions of the sheath have a diameter greater than the diameter of the crimped scaffolding; wherein the middle portion of the sheath is disposed over the scaffolding and the end portions of the sheath extend beyond the ends of the scaffolding over end portions of the balloon.

INCORPORATION BY REFERENCE

All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference, and as if each said individual publication or patent application was fully set forth, including any figures, herein.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows a process for fabricating a scaffolding of a polymer stent and crimping the fabricated stent to a balloon according to the invention. FIG. 2 depicts an axial cross-section of a flared restraining sheath.

FIG. 3 depicts an exemplary restraining sheath with a step-change in diameter between a middle portion and end portions.

FIG. 4 illustrates a method of expanding balloon ends of a crimped stent-balloon assembly using the restraining sheath of FIG. 2.

FIG. 5 depicts an expanded view of the proximal end of a restraining sheath disposed over a stent-balloon assembly of FIG. 4.

FIG. 6 depicts the expanded view of FIG. 5 after the balloon is depressurized.

FIG. 7 depicts and exemplary stent pattern 700 from US 2008/0275537.

FIG. 8 depicts the proximal end portion of pattern 700 in FIG. 7.

DETAILED DESCRIPTION

OF EMBODIMENTS

The “glass transition temperature,” Tg, is the temperature at which the amorphous domains of a polymer generally change from a brittle, vitreous state to a solid deformable or ductile state at atmospheric pressure. In other words, the Tg corresponds to the temperature where the onset of noticeable segmental motion in the chains of the polymer occurs. When an amorphous or semi-crystalline polymer is exposed to an increasing temperature, the coefficient of expansion and the heat capacity of the polymer both increase as the temperature is raised, indicating increased molecular motion. As the temperature is raised the actual molecular volume in the sample remains constant, and so a higher coefficient of expansion points to an increase in free volume associated with the system and therefore increased freedom for the molecules to move. The increasing heat capacity corresponds to an increase in heat dissipation through movement. Tg of a given polymer can be dependent on the heating rate and can be influenced by the thermal history of the polymer. Furthermore, the chemical structure of the polymer heavily influences the glass transition by affecting mobility.

Poly(lactide-co-glycolide) (PLGA) and Poly (L-lactide) (PLLA) are examples of a class of semi-crystalline polymers that may be used to form the scaffolding for the stent structures described herein. PLLA is a homopolymer and PLGA is a co-polymer. The percentage of glycolide (GA) in a scaffold constructed of PLGA may vary, which can influence the lower range of Tg. For example, the percentage of GA in the matrix material may vary between 0-15%. For PLLA, the onset of glass transition occurs at about 55 degrees Celsius. With an increase of GA from about 0% to 15% the lower range for Tg for PLGA can be correspondingly lower by about 5 degrees Celsius.

In one embodiment, a tube is formed by an extrusion of PLLA. The tube forming process described in US Pub. No. 2010/00025894 may be used to form this tube. The finished, solidified polymeric tube of PLLA may then be deformed in radial and axial directions by a blow molding process wherein deformation occurs progressively at a predetermined longitudinal speed along the longitudinal axis of the tube. For example, blow molding can be performed as described in U.S. Publication No. 2009/0001633. This biaxial deformation, after the tube is formed, can produce noticeable improvement in the mechanical properties of the stent structural members cut from the tube without this expansion. The degree of radial expansion that the polymer tube undergoes characterizes the degree of induced circumferential molecular or crystal orientation. In a preferred embodiment, the radial expansion ratio or RE ratio is about 450% of the starting tube\'s inner diameter and the axial expansion ratio or AE ratio is about 150% of the starting tube\'s length. The ratios RA and AE are defined in US Pub. No. 2010/00025894.

The above scaffolding\'s outer diameter may be designated by where it is expected to be used, e.g., a specific location or area in the body. The outer diameter, however, is usually only an approximation of what will be needed during the procedure. For instance, there may be extensive calcification that breaks down once a therapeutic agent takes effect, which can cause the stent to dislodge in the vessel. Further, since a vessel wall cannot be assumed as circular in cross-section, and its actual size only an approximation, a physician can choose to over-extend the stent to ensure it stays in place. For this reason, it is preferred to use a tube with a diameter larger than the expected deployed diameter of the stent.

In one embodiment the ratio of deployed to fully crimped diameter is about 2.5. In this embodiment, the crimped diameter corresponds to an outer diameter that is only about 40% of the starting diameter. Hence, when deployed the drug eluting stent is expected to increase in size up to about 2.5 times its stowed or crimped diameter size.

In one particular example, a stent is formed from a biaxially expanded tube having an outer diameter of 3.5 mm, which approximately corresponds to a deployed diameter (the stent may be safely expanded up to 4.0 mm within a lumen). When crimped on the balloon, the stent has an outer diameter of 1.3 mm, or about 37% of the starting tube diameter of 3.5 mm.

As discussed earlier, fabrication of a balloon-expanded polymer stent presents challenges that are not present in metallic stents. One challenge, in particular, is the fabrication of a polymer scaffolding, which means the load bearing network of struts including connectors linking ring elements or members that provide the radial strength and stiffness needed to support a lumen. In particular, there exists ongoing challenges in fabricating a polymer scaffolding (hereinafter “scaffolding”) that is capable of undergoing a significant degree of plastic deformation without loss of strength, e.g., cracks or fracture of struts. In the disclosed embodiments, a polymer scaffolding is capable of being deformed from a crimped diameter to at least 2.5 times the crimped diameter without significant loss of strength. Moreover, the polymer scaffolding is retained on a delivery balloon with a retention force that is significantly higher than previous methods of stent retention for a polymer stent.

One problem encountered with fabrication of a stent for delivery to a site in a body using a balloon is the ability of the stent to be safely crimped to the balloon so that an adequate retention force is established between the stent and balloon. A “retention force” for a stent crimped to a balloon means the maximum dislodgement force, applied to the stent along the direction of travel through a vessel, that the stent-balloon is able to resist before dislodging the stent from the balloon.

The invention addresses the unique challenges presented by a polymer stent that needs to be retained on a balloon. These challenges are present for several reasons. First, there is less space available between struts in a crimped state, which prevents balloon material from extending within gaps between struts. As a result, there is less abutment or interference between struts and balloon material, which interference/abutment has previously been relied upon to increase the retention force of the stent on a balloon. This condition is a result of the need to fabricate wider and thicker struts for the polymer stent, as compared to a metal stent, so as to provide adequate, deployed radial strength.

Second, a polymer, unlike a metal, is far more sensitive to changes in temperature. The art has previously relied on heat to retain a metal stent on a balloon. However, the temperatures that have previously been found effective for stent retention fall within a Tg of the polymer. Such temperature ranges have, therefore, been avoided since heating of a polymer scaffolding to within, or above Tg induces significant changes in the molecular orientation of the polymer material that result in loss of strength when the scaffolding is plastically deformed to its deployed diameter.

The retention force for a stent on a balloon is set by a process of mounting the stent on a balloon which includes a crimping process. In the crimping process the stent is plastically deformed onto the balloon surface to form a fit that resists dislodgement of the stent from the stent. Factors affecting the retention of a stent on a balloon are many. They include the extent of surface-to-surface contact between the balloon and stent, the coefficient of friction of the balloon and stent surfaces, and the degree of protrusion or extension of balloon material between struts of the stent. In general, a preferred range of retention force for a stent is greater than 0.7 lb, 0.7 to 1.2 lb, or greater than 1.2 lb.

For a metal stent there are a wide variety of methods known for improving the retention force of a stent on a balloon via modification of one or more of the foregoing properties; however, many are not suitable or of limited usefulness for a polymeric stent, due to differences in mechanical characteristics of a polymer stent verses a metal stent as discussed earlier. Most notable among these differences is brittleness of the polymer material suitable for balloon-expanded stent fabrication, verses that of a metal stent. Whereas a metal stent may be deformed sufficiently to obtain a desired retention force, the range of deformation available to a polymer stent, while avoiding cracking or fracture-related problems, by comparison, is quite limited.

The art has previously devised methods for retaining a polymer stent on a delivery balloon in response to these challenges. Applicants and others have applied such previously devised methods to crimping polymeric stents. Initial approaches focused on enhancing the contribution to stent retention provided by the stent ends. In one example, the stent is crimped to the delivery balloon at a temperature well below the polymer\'s Tg, for example, about 30° C., as described in 20050119720. A method originally developed for improving retention of metal stents is then applied to the stent that is tightly crimped onto the balloon as described in U.S. Pat. No. 6,666,880 to Chiu et al. An expansion restraint is placed over the stent and the balloon. The restraint has an inner diameter equal to the outer diameter of the crimped stent. The stent is kept cool by a stent temperature controller and is thermally insulated while a portion of the catheter balloon extending beyond the edge of the stent is heated by a heat source. The balloon is pressurized which causes the balloon at the end of the stent to inflate and conform to the stent\'s geometry. Specifically, the expanded balloon ends form raised edges abutting the stent ends to resist dislodgement of the stent from the balloon. The expansion restraint prevents the balloon from extending beyond the outer diameter of the stent both in the gaps between struts and at then ends. Preventing balloon material from being pumped out beyond the stent outer surface was thought necessary for metal stents since metal stent have sharp edges that could cause pinholes in the balloon.

The above disclosed method provided a retention force between 0.5 and 0.7 lb. In one example, this process provided a retention force of about 0.35 lb. for a Poly (L-lactide) (PLLA) scaffolding crimped to a polymide-polyether block co-polymer (PEBAX) balloon. Although adequate, improvement in retention force was needed.

A second approach taken to obtaining improved stent retention focused on the interaction of the stent surface with the balloon and stent ends interaction with the balloon. This second approach did not include a step post-crimping that involved preferential inflation of the balloon at the ends of the stent, as described above. This second approach is described in U.S. patent application Ser. No. 12/772,116 to Jow et al. In this method, the crimping head reduces the stent diameter in stages as well as heating the stent. In addition, the balloon is pressurized during some of the stages so that the stent is crimped over an inflated balloon. This method resulted in significant improvement of the retention force of a polymeric stent on a balloon. The method is described in detail below.

During the development the approach of Jow et al., it was found, unexpectedly, that there is a certain degree of beneficial movement between interconnected polymer chains of a stent structure heated to temperatures just below Tg of the polymer when the stent is being crimped to a balloon, versus the same stent crimped to the balloon at a lower temperature, such as room temperature. For example, for a controlled temperature of between about 48 and 54 degrees, 48-50 degrees or 48 degrees Celsius it was found that a PLLA stent crimped to a balloon exhibited noticeable improvement in the retention force of the stent on the balloon, while not concomitantly producing unacceptable side effects for the deployed stent, e.g., excessive cracking or void formation, fracture or loss of memory in the material affecting its deployed radial stiffness qualities. The temperature range can also be 45 to 55 degrees Celsius.

A solution for improvement of the retention provided by Jow et al. was found from a series of studies involving increasing or varying balloon pressure during crimping, initiating stages of stent crimping including different rates, interim and final hold times at various crimper diameters, e.g., pre-crimping steps, or increasing the temperature of the stent while it was being crimped, or a combination of these factors. A preliminary study was conducted to determine whether modification of one or more of these factors in a polymer scaffold crimping process might improve stent retention. Thus, factors including temperature, hold time, balloon pressure force, pressure sequence, pressure initiation size, and speed of crimping were initially studied and results collected and studying under a multi-factored statistical approach to identify the key factors altering scaffold retention to a balloon. For this preliminary study, an iris crimper was used to crimp the stent. The scaffold was heated by heating the crimper jaws, although the scaffold may alternatively be heated by a forced hot air gas or heated fluid for expanding the balloon.

Based on this multi-factored study it was hypothesized that a carefully chosen temperature range might improve results, which came as a surprise. It was previously believed there would be little, or no benefit to heating a scaffold during crimping because either a raised temperature would induce molecular motion destroying the chain alignment needed to give the scaffold its deployed strength properties, or the temperature was too low to affect either the scaffold or the balloon.

A more narrow-focused study was conducted to identify a temperature range that might produce a significant difference in scaffold retention force without causing adverse effects on the deployed or crimped scaffold. TABLES 1 and 2, below, provide statistics for a retention force of a polymer scaffold-balloon as a function of the scaffold temperature during crimping. The crimping process was similar to that described in FIG. 1. Two studies were conducted, one for scaffold temperatures of 37-48° C. and the other for scaffold temperatures of 48-80° C., respectively. Both tests evaluated the retention force for a PLLA scaffolding having the pattern described in US 2010/0004735 and crimped to a PEBAX balloon. More specifically, a first study included conducting several trials at each of 37° C., 42.5° C. and 48° C. and a second study included conducting several trials at each of 48° C., 55° C., 65° C. and 80° C.

TABLES 1 and 2 show the mean and standard deviation in retention force (obtained using a standard pull-off test procedure) for an 18 mm PLLA scaffolding having the pattern described in US 2010/0004735 and crimped to a PEBAX balloon. “Number” refers to the number of trials run at the corresponding scaffold temperatures.



Download full PDF for full patent description/claims.

Advertise on FreshPatents.com - Rates & Info


You can also Monitor Keywords and Search for tracking patents relating to this Method of increasing stent retention of bioabsorbable scaffolding with a sheath patent application.
###
monitor keywords



Keyword Monitor How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.  
Start now! - Receive info on patent apps like Method of increasing stent retention of bioabsorbable scaffolding with a sheath or other areas of interest.
###


Previous Patent Application:
Introducer with ratchet handle drive
Next Patent Application:
Pre-positioned anastomosis device and related methods of use
Industry Class:
Prosthesis (i.e., artificial body members), parts thereof, or aids and accessories therefor
Thank you for viewing the Method of increasing stent retention of bioabsorbable scaffolding with a sheath patent info.
- - - Apple patents, Boeing patents, Google patents, IBM patents, Jabil patents, Coca Cola patents, Motorola patents

Results in 0.64082 seconds


Other interesting Freshpatents.com categories:
Amazon , Microsoft , IBM , Boeing Facebook

###

All patent applications have been filed with the United States Patent Office (USPTO) and are published as made available for research, educational and public information purposes. FreshPatents is not affiliated with the USPTO, assignee companies, inventors, law firms or other assignees. Patent applications, documents and images may contain trademarks of the respective companies/authors. FreshPatents is not affiliated with the authors/assignees, and is not responsible for the accuracy, validity or otherwise contents of these public document patent application filings. When possible a complete PDF is provided, however, in some cases the presented document/images is an abstract or sampling of the full patent application. FreshPatents.com Terms/Support
-g2-0.1852
     SHARE
  
           

FreshNews promo


stats Patent Info
Application #
US 20120290063 A1
Publish Date
11/15/2012
Document #
13103882
File Date
05/09/2011
USPTO Class
623/111
Other USPTO Classes
29515
International Class
/
Drawings
8


Scaffolding


Follow us on Twitter
twitter icon@FreshPatents